SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RNXT

RenovoRx, Inc. (NASDAQ:RNXT)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.94-$0.11 (-10.29%)
 
Market cap
$45.5M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 26, 2021
Market Cap$45.45M+18.4%
Revenue (ttm)$2.78M+199.1%
Net Income-$13.02M-17.2%
EPS-$0.32+13.7%
Shares Out48.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume477,326
Open$1.01
Previous Close$1.05
Day's Range$0.94 - $1.03
52-Week Range$0.77 - $2.59
Beta0.97
AnalystsBuy
Price Targetn/a
Earnings DateMar 29, 2027
-10.48% (1D)
No price history available.

About RNXT

RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.

Address
4546 El Camino Real, Mountain View, CA, 94040, US
Market Cap
45 million
Employees
17
Industrial Classification
Biotechnology

RenovoRx, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
6th Percentile Overall Score
RNXT InsiderScore:39 / 99

RenovoRx, Inc. scored higher than 6% of companies evaluated by InsiderBuying, and ranked 84th out of 102 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at RenovoRx, Inc. bought $46.5K of stock across 1 purchase in the last 90 days, the largest of them $46.5K.

Stake Increase

The average purchase added about 6% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$130.98K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 Sell

1 firm rating RNXT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From RNXT’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-10.29%
5 Days
-6.73%
1 Month
-23.41%
6 Months
+6.85%
1 Year
+18.39%

$RNXT stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in RNXT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by RNXT's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

RNXT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New RNXT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to RNXT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in RNXT

VTIVanguard Morningstar Total Stock Market ETF$1.24M
VXFVanguard Extended Market ETF$604.54K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from RNXT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
35.48
Analyst Ratings
40% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
14
Sells
0
Buy Value
$130.98K
Distinct Buyers
4

Insider Score Trend Over Time

-6.5 since Nov 17
0255075100Nov 17 — Insider Score 42.0Nov 18 — Insider Score 40.6Nov 19 — Insider Score 39.1Nov 20 — Insider Score 36.2Nov 21 — Insider Score 35.5Nov 17Nov 19Nov 21

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.